GraphPad Acquires Biomatters
Summary
GraphPad is acquiring Biomatters to build a broader life sciences software platform. The combined company will focus on data analysis and technology for scientific research workflows. GraphPad says the deal will accelerate investment in innovation and better support its global customer base. Both brands will continue to operate after the acquisition, while the platform expands around GraphPad Prism and Geneious capabilities.
Classifications
industries
InsurTech
applications
Accounting and Taxes
AskAI Classifications
Labels
Bioinformatics Software
Scientific Research Software
Molecular Biology Software
Linked Companies
Geneious
$1M to $5M
GraphPad Software
$1M to $5M